The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABIVAX SA SPONSORED ADS 00370M103   183,760 13,900 SH   SOLE   13,900 0 0
ADICET BIO INC COM 007002108   21,160 17,488 SH   SOLE   17,488 0 0
BERKSHIRE HATHAWAY INC DEL CL B NEW 084670702   417,070 1,025 SH   SOLE   1,025 0 0
COMPASS THERAPEUTICS INC COM 20454B104   43,465 43,465 SH   SOLE   43,465 0 0
CONTEXT THERAPEUTICS INC COM 21077P108   36,899 18,403 SH   SOLE   18,403 0 0
KYVERNA THERAPEUTICS INC COM 501976104   172,359 22,981 SH   SOLE   22,981 0 0
LEXEO THERAPEUTICS INC COM 52886X107   286,331 17,851 SH   SOLE   17,851 0 0
MIND MEDICINE INC COM NEW 60255C885   219,059 30,383 SH   SOLE   30,383 0 0
MOLECULAR TEMPLATES INC COM NEW 608550208   157,396 136,866 SH   SOLE   136,866 0 0
REZOLUTE INC COM NEW 76200L309   5,671,558 1,318,967 SH   SOLE   1,318,967 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103   1,016,921 1,869 SH   SOLE   1,869 0 0
XERIS BIOPHARMA HOLDINGS INC COM 98422E103   11,505,033 5,113,348 SH   SOLE   5,113,348 0 0